{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nConjugated protein and the anti-CD154 antibody of CD154 of the present invention (comprising antibody fragment and derivative) is combined with usefulness and specificity height for what suppress CD154 and CD40, for example has 20pM-1.5 \u03bc M(and comprises end points) IC50.\nIn certain embodiments, CD154 of the present invention conjugated protein (for example anti-CD154 antibody) can have the IC50 of 20pm-500pm, 50pm-500pm or 100pm-500pm.\nFor example, in certain embodiments, as (for example, by surface plasma body resonant vibration) record CD154 conjugated protein (for example anti-CD154 antibody) and comprise end points with 50nM-1pM() and K<sub>D</sub>Dissociate with human CD 154 (human CD 40 L).\nFor example, the K of human CD 154<sub>D</sub>Can be 50pm-1pm, 20pm-1pm or even 10pm-1pm.\nIn some embodiments, the K of human CD 154<sub>D</sub>Less than 20pM.\nIn other embodiments, the K of human CD 154<sub>D</sub>Less than 10pM."}
{"final_json": [{"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "20pM-1.5 \u03bcM", "unit": "pM-\u03bcM", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "20pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "50pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "100pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "Kd", "value": "50nM-1pM", "unit": "nM-pM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human CD 154", "binding_metric": "Kd", "value": "50pm-1pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human CD 154", "binding_metric": "Kd", "value": "20pm-1pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human CD 154", "binding_metric": "Kd", "value": "10pm-1pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human CD 154", "binding_metric": "Kd", "value": "<20pM", "unit": "pM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "human CD 154", "binding_metric": "Kd", "value": "<10pM", "unit": "pM", "is_logarithmic": false}]}
{"raw_mentions": "Figure 12 lists by selecting the table of the isolating rat anti human CD 154 of lymphocyte antibody method (SLAM) antibody.This table shows and exists with these antibody, CD40 binding assay and ICAM-1 raise the K that obtains in the assay method <sub>d</sub>And IC<sub>50</sub>Value.The data that obtain with antibody 342 highlight.\nFigure 18 is the different embodiments that shows humanization 342gL4gH1 antibody (comprising Fab ' fragment and antibody-PEG conjugate),, CD40 binding assay, ICAM-1 raise the K that obtains in assay method and the CD40L competition binding assay <sub>d</sub>And IC<sub>50</sub>The table of value."}
{"final_json": [{"molecule_name": "antibody 342", "protein_target_name": "CD40", "binding_metric": "IC50", "value": "<sub>d</sub>", "unit": null, "is_logarithmic": false}, {"molecule_name": "humanization 342gL4gH1 antibody", "protein_target_name": "CD40", "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nTherefore, in certain embodiments, the conjugated protein and anti-CD154 antibody of CD154 of the present invention (comprising antibody fragment and derivative) is for the IC50 that is combined with usefulness and specificity height (for example 10pM-1.5 \u03bc M(comprises end points) that suppresses CD154 and CD40).\nIn certain embodiments, CD154 of the present invention conjugated protein (for example antibody) can have the IC50 of 10pm-500pm, 50pm-500pm, 100pm-500pm, 250pm-750pm, 500pm-1 \u03bc M or 750pm-1.5 \u03bc M.\nFor example, if using this antibody in the vitro efficacy assay method as described in example 7 above, then can not demonstrate any significant basically antagonistic action, maybe can demonstrate with positive control (for example CD154 part) and compare 1%, 2%, 3%, 5% or 10% antagonistic action above control treatment."}
{"final_json": [{"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "10pM-1.5 \u03bcM", "unit": "pM, \u03bcM", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "10pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "50pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "100pm-500pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "250pm-750pm", "unit": "pm", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "500pm-1 \u03bcM", "unit": "pm, \u03bcM", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody", "protein_target_name": "CD154", "binding_metric": "IC50", "value": "750pm-1.5 \u03bcM", "unit": "pm, \u03bcM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": "1%, 2%, 3%, 5% or 10%", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nGraftka\uff081/Ms\uff09 kd\uff08l/s\uff09 KD\uff08M\uff09 KD\uff08pM\uff09 gL4gH1 1.53E+07 6.97E-05 4.55E-12 4.55"}
{"final_json": [{"molecule_name": "Graftka", "protein_target_name": null, "binding_metric": "KD", "value": "4.55E-12", "unit": "M", "is_logarithmic": false}, {"molecule_name": "Graftka", "protein_target_name": null, "binding_metric": "KD", "value": "4.55", "unit": "pM", "is_logarithmic": false}, {"molecule_name": "Graftka", "protein_target_name": null, "binding_metric": "kd", "value": "6.97E-05", "unit": "l/s", "is_logarithmic": false}, {"molecule_name": "Graftka", "protein_target_name": null, "binding_metric": "1/Ms", "value": "1.53E+07", "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe Kd value of passing through the isolating anti-CD154 antibody of SLAM that obtains is shown in Figure 12 and 18.\nCD40 by the isolating anti-CD154 antibody of SLAM is shown in Figure 12 and 18 in conjunction with the IC50 value.\nThe part of using XLfit to wrap as Activity Base obtains the IC50 value from data."}
{"final_json": [{"molecule_name": "anti-CD154 antibody of SLAM", "protein_target_name": "CD154", "binding_metric": "Kd", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody of SLAM", "protein_target_name": "CD40", "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nNone of the sentences in the provided text contain all four required components: a specific molecule name, ID or other identifier, a bioactivity metric, a specific numeric value for that metric, and a unit for that value. However, one sentence mentions an IC50 value, but it does not provide a specific numeric value or unit:\n\n\nThe IC50 value is used to measure the relative effectiveness of anti-CD154 antibody."}
{"final_json": [{"molecule_name": "anti-CD154 antibody", "protein_target_name": null, "binding_metric": "IC50", "value": null, "unit": null, "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nAnti-CD154 antibody, the anti-CD154 antibody of variant or damping fluid are prepared as 1/2 log10 dilution thing in 1 * mensuration damping fluid, and directly are distributed in each hole, with the Fc \u03b3 RI-His-GST, Fc \u03b3 RIIIa-His-GST, Fc \u03b3 RIIa-His-GST or other FcR at 0.5nM final concentration.\n\n\nThe anti-CD154 antibody of biotinylated wild-type (for example, IgG1 antibody) measured in the damping fluid add each Kong Zhongzhi 5nM final concentration.\n\n\nThe anti-GST acceptor bead of 100 \u03bc g/ml is added each hole, and make flat board incubation 1 hour at room temperature in the dark, with the Streptavidin donor bead of 100 \u03bc g/ml added in each flat board, and of short duration centrifugal after, make flat board incubation 1.5 hours at room temperature.\n\n\nRecombinant soluble human CD 154 part (Karpusas et al., Structure, 15 with 50 \u03bc l10 \u03bc g/ml; 3(12): 1426(1995) under 4 \u2103 in PBS the bag (Nalge-Nunc Rochester, NY is USA) after carrying out yesterday by 96 hole Maxisorb ELISA flat boards, with 200 \u03bc l/ hole blocking-up/dilution buffer liquid (0.1M Na2HPO4, pH7.0,1M NaCl, 0.05%Tween20,0.1% gelatin) blocked at least 1 hour.\n\n\nAntibody to be tested dilutes in blocking-up/dilution buffer liquid, with 3 times of dilutions since 15 \u03bc g/ml, and with 2 \u03bc g/ml Sigma people C1q(C0660 that dilute in blocking-up/dilution buffer liquid), and incubation 1.5 hours at room temperature.\n\n\nThe aliquots containig of people C1q can add in each hole, and incubation 2 hours at room temperature, with 100 \u03bc l sheep anti C1Q peroxidase conjugated can be added in each hole, and incubation 1 hour at room temperature, and contains OPD(o-phenylenediamine dihydrochloride (Sigma)) 100 \u03bc l substrate buffer solutions can add in each hole, and allow observed oxidizing reaction to occur and carry out 30 minutes by xanchromatic."}
{"final_json": [{"molecule_name": "Anti-CD154 antibody", "protein_target_name": "Fc \u03b3 RI-His-GST, Fc \u03b3 RIIIa-His-GST, Fc \u03b3 RIIa-His-GST", "binding_metric": null, "value": "0.5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-CD154 antibody of biotinylated wild-type", "protein_target_name": null, "binding_metric": null, "value": "5", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "anti-GST acceptor bead", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Streptavidin donor bead", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Recombinant soluble human CD154", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Antibody to be tested", "protein_target_name": null, "binding_metric": null, "value": "15", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "C1q", "protein_target_name": null, "binding_metric": null, "value": "2", "unit": "\u03bcg/ml", "is_logarithmic": false}, {"molecule_name": "Sheep anti C1Q peroxidase conjugated", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null, "is_logarithmic": false}]}
